ICU superbug study reveals resistance patterns
NCT ID NCT07172932
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This completed study looked at 314 ICU patients with bloodstream infections caused by Enterobacterales bacteria. Researchers identified how often these bacteria were resistant to common antibiotics and what patient factors increased the risk. The goal was to understand resistance patterns to help guide better treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better identify and manage antibiotic-resistant infections in ICU patients, potentially reducing deaths.
- What could go wrong
- This is a completed observational study, not a treatment trial. It only identifies risk factors and resistance patterns, so it cannot directly improve patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIBIOTIC RESISTANT INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ankara Bilkent City Hospital
Çankaya, Ankara, 06800, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who sleeps poorly after heart surgery?
- CAR-T breakthroughs come with infection risks – new study aims to decode them
- Probiotics join the fight against superbugs in the gut
- Antibiotic-Infused bone graft could slash infection risk in hip replacements
- Can a half-day training sharpen ICU nurses' ability to detect hidden seizures?
- Superbug sleuths decode the DNA of drug-resistant e. coli to stop its spread